TradingView
warrenhochfeld
1 nov. 2017 19:02
Dynavax final breakout ahead of PDUFA Heplisav announcement
Long
NASDAQ:DVAX
15
Dynavax Technologies Corporation
NASDAQ
Description
⋅
1 nov. 2017 19:02
Start of final bull run ahead of 9th November FDA announcement of Heplisav . $28 price projection. Final buy opportunity at $20
Trend Analysis
Beyond Technical Analysis
Plus